Search results
Results From The WOW.Com Content Network
Ophthalmic drug administration is the administration of a drug to the eyes, most typically as an eye drop formulation. Topical formulations are used to combat a multitude of diseased states of the eye. These states may include bacterial infections, eye injury, glaucoma, and dry eye. [1]
Syringe designed saline drops (e.g. Wallace Cameron Ultra Saline Minipod) are distributed in modern needle-exchange programmes as they can be used efficiently either by injection or ophthalmic (if the drug is potent in small doses) route of administer which is compared to intravenous use; by demonstration, the elimination of latanoprost acid ...
System: Eye and visual system: Significant diseases: Cataract, retinal disease (including diabetic retinopathy and other types of retinopathy), glaucoma, corneal disease, eyelid and orbital disorders, uveitis, strabismus and disorders of the ocular muscles, ocular neoplasms (malignancies, or cancers, and benign eye tumors), neuro-ophthalmologic disorders (including disorders of the optic nerve)
Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) [2] marketed in the US as an ophthalmic solution (brand names Prolensa and Bromday, [3] prior formulation brand name Xibrom, which has since been discontinued) by ISTA Pharmaceuticals for short-term, local use. Prolensa and Bromday are the once-daily formulation of bromfenac, while ...
Fluorescein is used to help in the diagnosis of a number of eye problems. [3] When applied as a drop or within a strip of paper to the surface of the eye it is used to help detect eye injuries such as foreign bodies and corneal abrasions.
[2] [3] It is available as a 0.1% ophthalmic solution . [1] [4] Side effects of dipivefrine include local eye reactions among others. Dipivefrine is a prodrug of epinephrine (adrenaline) and hence acts as a non-selective adrenergic receptor agonist. [5]
Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. [1] [2] [3] In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension.
Ketotifen is an antihistamine medication and a mast cell stabilizer used to treat allergic conditions such as conjunctivitis, asthma, and urticaria (hives).Ketotifen is available in ophthalmic (eye drops or drug-eluting contact lenses) and oral (tablets or syrup) forms: the ophthalmic form relieves eye itchiness and irritation associated with seasonal allergies, while the oral form helps ...